Improved radiotherapy approaches for prostate cancer treatment
- Submitting institution
-
Institute of Cancer Research: Royal Cancer Hospital (The)
- Unit of assessment
- 1 - Clinical Medicine
- Summary impact type
- Health
- Request cross-referral to
- -
- Is this case study continued from a case study submitted in 2014?
- No
- Underpinning research subjects
-
- Other Physical Sciences
- Clinical Sciences
- Oncology And Carcinogenesis
3. References to the research
5. Sources to corroborate the impact
Additional contextual information
Grant funding
| Grant number |
Value of grant |
| MQAB |
£0 |
| SP2312/021 |
£0 |
| None given (NIHR additional support) |
£0 |
| C8262/A7253 |
£990,253 |
| C1491/A9895 |
£5,010,603 |
| C1491/A15955 |
£5,901,462 |
| C46/A3970 |
£3,638,224 |
| C46/A10588 |
£2,971,500 |
| C33589/A19727 |
£2,628,163 |
| BRC-2011-10059 |
£61,543,735 |
| IS-BRC-1215-20021 |
£43,074,315 |
| C1491/A25351 |
£6,456,485 |
| A115 |
£292,291 |
| None given (NIHR Senior Investigator 2012) |
£45,000 |
| A12518 |
£278,175 |
| C5907/A11880 |
£78,426 |
| None given (NIHR Senior Investigator 2008) |
£45,000 |
| None given (NIHR BRC 2007) |
£46,800,000 |
| None given (DoH additional award) |
£300,000 |
| None given (CRUK grant 1999) |
£2,700,000 |
- Countries
-
- UK
- US
- Europe
- Australia
- New Zealand
- Formal partners
-
- The Royal Marsden NHS Foundation Trust
- Funding programmes
-
- Medical Research Council: RT01 randomised trial: Escalated-dose versus control-dose conformal radiotherapy for prostate cancer
- Cancer Research UK: Academic Radiotherapy Unit programme grant
- National Institute for Health Research: Stage 2 additional support from the Department of Health
- Cancer Research UK: CHHIP: a randomised phase III multicentre trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer
- Cancer Research UK: ICR Clinical Trials and Statistic Unit Programme Grant (2008 to 2013)
- Cancer Research UK: ICR Clinical Trials and Statistic Unit Programme Grant (2013 to 2018)
- Cancer Research UK: Optimisation of Management in Clinical Oncology (2004)
- Cancer Research UK: Optimisation of Management in Clinical Oncology (2009)
- Cancer Research UK: Advances In Physics For Precision Radiotherapy
- The National Institute for Health Research Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research (2012)
- The National Institute for Health Research Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research (2017)
- Cancer Research UK: ICR Clinical Trials and Statistic Unit Programme Grant (2018 to 2023)
- National Institute for Health Research: A randomised phase II trial assessing Post-Operative use of ProSpare, a rectal obturator in prostate cancer radiotherapy
- National Institute for Health Research: NIHR Senior Investigator Award 2012
- Cancer Research UK: An evaluation of biomarkers in hypofractionated and dose escalated prostate cancer radiotherapy: Trans-CHHiP Study
- Cancer Research UK: A randomised phase II trial of Prostate and pelvIc Versus prOstaTe ALone radiotherapy treatment volumes using high dose IMRT for locally advanced prostate cancer: PIVOTAL
- National Institute for Health Research: NIHR Senior Investigator Award 2008
- The National Institute for Health Research Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research (2007)
- Department of Health: DoH additional award to CRFF/NCRI Prostate Cancer Collaborative
- Cancer Research UK: Optimisation of management in clinical oncology (1999)
- Global research identifiers
-
- grid.420006.0
- grid.11485.39
- grid.451056.3
- grid.57981.32
- Name of funders
-
- Medical Research Council
- Cancer Research UK
- National Institute for Health Research
- Department of Health
- Researcher ORCIDs
-
- 0000-0002-3954-2806
- 0000-0001-5999-5020
- 0000-0003-3604-1990
- 0000-0001-6512-124X
- 0000-0002-0425-584X
